top of page
Gotham__Group Gotham White.png

Search Results

563 items found for ""

  • FACIT-Sp-12 Languages

    BACK FACIT-Sp-12 Languages Arabic Bengali Burmese Chinese - Traditional Chinese - Simplified Croatian Czech Danish Dutch English Farsi French German Greek Hebrew Hindi Hungarian Indonesian Italian Japanese Korean Lithuanian Malay Malayalam Marathi Nepali Norwegian Polish Portuguese Serbian Sinhala Spanish Slovak Slovene Swahili Swedish Tamil Telugu Thai Turkish Vietnamese

  • FACIT-Pal-14 Languages

    BACK FACIT-Pal-14 Languages Bengali Burmese Chinese - Simplified Chinese – Traditional Dutch English Farsi German Greek Hindi Indonesian Japanese Malay Malayalam Portuguese Sinhala Spanish Swahili Tagalog Tamil Telugu Thai Turkish Vietnamese

  • FACIT-Sp Languages

    BACK FACIT-Sp Languages Arabic Bengali Burmese Chinese - Traditional Chinese - Simplified Croatian Czech Danish Dutch English Farsi French German Greek Hebrew Hindi Hungarian Indonesian Italian Japanese Korean Lithuanian Malay Malayalam Marathi Norwegian Polish Portuguese Serbian Sinhala Spanish Slovak Slovene Swahili Swedish Tamil Telugu Thai Turkish Vietnamese

  • FACIT-Pal Languages

    BACK FACIT-Pal Languages Bengali Burmese Chinese – Simplified Dutch English German Greek Hindi Indonesian Japanese Malay Malayalam Portuguese Sinhala Spanish Swahili Tagalog Tamil Telugu Thai Turkish Vietnamese

  • FACIT-GP5 Languages

    BACK FACIT-GP5 Languages Albanian Afrikaans Arabic Armenian Assamese Belarusian Bengali Bosnian Bulgarian Burmese Catalan Cebuano Chinese - Simplified Chinese - Traditional Croatian Czech Danish Dutch English Estonian Farsi Finnish French Galician Georgian German Greek Gujarati Haitian Creole Hebrew Hiligaynon Hindi Hungarian Icelandic Ilokano Indonesian Italian Japanese Kannada Kazakh Korean Latvian Lithuanian Luganda Macedonian Malay Malayalam Maltese Marathi Mongolian Montenegrin Norwegian Odia Polish Portuguese Punjabi Romanian Russian Sepedi Serbian Sesotho Setswana Sinhala Slovak Slovene Spanish Swahili Swedish Tagalog Tamil Telugu Thai Turkish Ukrainian Urdu Vietnamese Welsh Wolof Xhosa Zulu

  • FACIT-Fatigue Languages

    BACK FACIT-Fatigue Languages Afrikaans Albanian Arabic Armenian Assamese Ateso Azerbaijani Belarusian Bemba Bengali Bosnian Bulgarian Burmese Catalan Cebuano Chinese - Simplified Chinese - Traditional Croatian Czech Dagbani Danish Dholuo Dutch English Estonian Ewe Fante Farsi Finnish French Galician Georgian German Greek Gujarati Haitian Creole Hausa Hebrew Hiligaynon Hindi Hungarian Igbo Ilokano Indonesian Icelandic Italian Japanese Kannada Kapampangan Kazakh Korean Latvian Lithuanian Lumasaba Luganda Lugwere Lusoga Macedonian Malay Malayalam Marathi Marwari Montenegrin Norwegian Nyanja Odia Polish Portuguese Punjabi Romanian Russian Sepedi Serbian Sesotho Setswana Sinhala Slovak Slovene Spanish Swahili Swedish Tagalog Tamil Telugu Thai Tonga Tumbuka Turkish Twi Ukrainian Urdu Vietnamese Xhosa Yoruba Zulu

  • FACIT-F Languages

    BACK FACIT-F Languages Afrikaans Albanian Arabic Bengali Bosnian Bulgarian Burmese Catalan Cebuano Chinese - Simplified Chinese - Traditional Croatian Czech Danish Dutch English Estonian Finnish French Georgian German Greek Gujarati Haitian Creole Hebrew Hiligaynon Hindi Hungarian Icelandic Ilokano Indonesian Italian Japanese Kannada Kazakh Korean Latvian Lithuanian Macedonian Malay Malayalam Marathi Montenegrin Norwegian Odia Polish Portuguese Punjabi Romanian Russian Serbian Sesotho Setswana Sinhala Slovak Slovene Spanish Swedish Tagalog Tamil Telugu Thai Turkish Ukrainian Urdu Vietnamese Xhosa Zulu

  • COST Languages

    BACK COST Languages Amharic Arabic Bengali Chinese - Simplified Chinese – Traditional Czech Danish Dutch English Finnish French German Greek Hebrew Hindi Hungarian Indonesian Italian Kannada Korean Lithuanian Malay Marathi Nepali Portuguese Russian Sinhala Slovak Slovene Spanish Swedish Tamil Telugu

  • CRRS English Downloads

    BACK CRRS English Downloads Download PDF Download DOC

  • FACT-ES Languages

    BACK FACT-ES Languages Afrikaans Arabic Armenian Bengali Burmese Chinese - Traditional Chinese - Simplified Croatian Czech Danish Dutch English Farsi Finnish French German Greek Gujarati Haitian Creole Hebrew Hindi Hungarian Italian Japanese Kannada Korean Malay Malayalam Marathi Mongolian Norwegian Odia Polish Portuguese Punjabi Romanian Russian Sepedi Serbian Spanish Swedish Tagalog Tamil Telugu Thai Turkish Ukrainian Urdu Vietnamese Zulu

  • FACT-CSI and FACT-NET

    FACT-CSI and FACT-NET Functional Assessment of Cancer Therapy - Carcinoid Syndrome Symptom Index For patients with carcinoid syndrome LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview The FACT-CSI is a 24-item instrument for patients with carcinoid syndrome that can be scored as a single, multidimensional symptom index, or sub-scored by domain (disease-related physical symptoms, disease-related emotional symptoms, treatment side effects, and functional well-being), meeting FDA guidance recommendations while allowing maximum flexibility for both global and targeted symptom evaluation. Its development followed FDA guidelines for the patient-reported outcome measures, which emphasizes improvement in tumor-related symptoms or delays in symptom progression as evidence of clinical benefit for patients in oncology drug trials. Methods consistent with the FDA guidance were utilized along with prior experience developing 11 National Comprehensive Cancer Network (NCCN) symptom indexes to identify the highest priority symptoms and concerns of patients with GINET, PNET, and LNET, and of patients with CS, to inform the development of a set of NET symptom indexes appropriate for use in both clinical trial and clinic settings. MEASURE NAME: Functional Assessment of Cancer Therapy - Carcinoid Syndrome Symptom Index (FACT-CSI) / FACT-NET VERSION: 4 NUMBER OF ITEMS: FACT-CSI - 24 items FACT-GINET - 18 items FACT-GINET + CSI - 29 items FACT-LNET - 17 items FACT-LNET + CSI - 30 items FACT-PNET - 19 items FACT-PNET + CSI - 29 items PATIENT POPULATION: Patients 18 years and older with carcinoid syndrome, GINET, PNET or LNET RECALL PERIOD: Past 7 days RESPONSE SCALE: 5 point Likert-type scale DATA COLLECTION: Paper and electronic ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: CSI, GINET, LNET, PNET TIME FOR COMPLETION: 5-10 minutes SCORING: Manual scoring template, some items are reverse scored. Subscale scores and total scores possible. RELATED MEASURES: FACT-Ga , FACT-Hep , FACT-L DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the FACT-CSI can be obtained by registering for permission. Users are not permitted to translate the FACT-CSI without permission from FACIT.org. Permission from FACIT.org to translate the FACT-CSI may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system. Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Shaunfield S, Webster K, A, Kaiser K, Greene G, J, Yount S, E, Lacson L, Benson A, B, Halperin D, M, Yao J, C, Singh S, Feuilly M, Marteau F, Cella D: Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom Index. Neuroendocrinology 2021;111:850-862. doi: 10.1159/000511482. Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures FACT-Ga Functional Assessment of Cancer Therapy – Gastric LEARN MORE FACT-Hep Functional Assessment of Cancer Therapy – Hepatobiliary LEARN MORE FACT-L Functional Assessment of Cancer Therapy – Lung LEARN MORE

  • FACT-BMT

    FACT-BMT Functional Assessment of Cancer Therapy - Bone Marrow Transplantation For patients undergoing Bone Marrow Transplantation LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview The Functional Assessment of Cancer Therapy – Bone Marrow Transplantation (FACT-BMT) is a valid and reliable measure of five dimensions of quality of life in bone marrow transplant patients. Items were selected from a list produced by 7 oncology experts and 15 patients designed to assess content not represented in the FACT-G. 182 patients completed the FACT-BMT at baseline prior to bone marrow transplantation. An analysis measuring sensitivity to change was performed with 74 patients after transplantation and 60 patients over the 3 timepoints of baseline, hospital discharge and 100 days. The FACT-BMT and all subscales were correlated, sensitivity to change was measured, and internal consistency for each scale was calculated. The FACT-BMT was able to discriminate patients on the basis of performance status rating and also demonstrated sensitivity to change over time. It has good psychometric properties and is an excellent choice for use in bone marrow transplantation clinical trials. MEASURE NAME: Functional Assessment of Cancer Therapy - Bone Marrow Transplantation (FACT-BMT) VERSION: 4 NUMBER OF ITEMS: 50 PATIENT POPULATION: Cancer patients 18 years and older undergoing bone marrow transplantation RECALL PERIOD: Past 7 days RESPONSE SCALE: 5 point Likert-type scale DATA COLLECTION: Paper and electronic ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, Functional Well-Being, Bone Marrow Transplantation Subscale TIME FOR COMPLETION: 10-15 minutes SCORING: Manual scoring template, some items are reverse scored. Subscale scores, total scores and TOI scores possible. SAS/SPSS algorithms available. RELATED MEASURES: FACT-BRM , FACT/GOG-NTX , FACT-BP DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the FACT-BMT can be obtained by registering for permission. Users are not permitted to translate the FACT-BMT without permission from FACIT.org. Permission from FACIT.org to translate the FACT-BMT may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system. Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Bieri, S., Roosnek, E., Helg, E., Verholen, F., Robert, D., Chapuis, B., Passweg, J., Miralbell, R., & Chalandon, Y. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplantation 2008; 42: 819–827. doi:10.1038/bmt.2008.253. Cohen, M., Rozmus, C., Mendoza, T., Padhye, N., Neumann, J., Gning, I., Aleman, A.., Giralt, S., & Cleeland, C. Symptoms and Quality of Life in Diverse Patients Undergoing Hematopoietic Stem Cell Transplantation. Journal of Pain and Symptom Management 2012; 44(2): 168-180. doi:10.1016/j.jpainsymman.2011.08.011. Heinonen, H., Volin, L., Uutela, A., Zevon, M. Barrick, C.,& Ruutu, T. Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. Ann Hematol 2001; 80: 137–143.. doi: 10.1007/s002770000249. Herzberg, P., Lee, S., Heussner, P., Mumm, F. Hilgendorf, I., von Harsdorf, S., Hemmati, P., Rieger, K., Greinix, H., Freund, M., Holler, E., & Wolff, D. Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center. Bone Marrow Transplantation 2013; 48: 129–134. doi:10.1038/bmt.2012.83. Kopp M, Schweigko¯er H, Holzner B, Nachbaur D, Niederwieser D, Fleischhacker W, Kemmler G, Sperner-Unterweger B. EORTC QLQC30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison. European Journal of Haematology 2000; 65: 97-03. Lau, A., Chang, C., Tai, J., Eremenco, S., Liang, R., Lie, A., Fong, D., & Lau, C. Translation and validation of the Functional Assessment of Cancer Therapy–Bone Marrow Transplant (FACT-BMT) Version 4 quality of life instrument into traditional Chinese. Bone Marrow Transplantation 2002; 29: 41–49. doi: 10.1038/sj/bmt/1703313. McQuellon, R.P., Russell, G.B., Cella, D.F., Craven, B.L., Brady, M., Bonomi, A., & Hurd, D.D. Quality of life measurement in bone marrow transplantation: Development of the Functional Assessment of Cancer Therapy - Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplantation 1997; 19: 357-368. McQuellon, R., Russell, G., Rambo, T., Craven, B., Radford, J., Perry, J., Cruz, J., & Hurd, D. Quality of life and psychological distress of bone marrow transplant recipients: the ‘time trajectory’ to recovery over the first year. Bone Marrow Transplantation 1998; 21: 477–486. Pidala, J., Kurland, B., Chai, X., Vogelsang, G., Weisdorf, D., Pavletic,S., Cutler, C., Majhail,N., & Lee, S. Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium. Hematologica 2011; 96(10): 1528-1535. doi: 10.3324/haematol.2011.046367. Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures FACT-BRM Functional Assessment of Cancer Therapy - Biologic Response Modifiers LEARN MORE FACT/GOG-NTX Functional Assessment of Cancer Therapy/Gynecologic Oncology Group – Neurotoxicity LEARN MORE FACT-BP Functional Assessment of Cancer Therapy - Bone Pain LEARN MORE

bottom of page